Skip to main content
Premium Trial:

Request an Annual Quote

A Penny for Your Thoughts

We've got a couple of opportunities for you to share your thoughts. (Oh, come on. It's Friday. What else will you be doing?)

NIH's National Institute of General Medical Sciences is conducting an assessment of the Protein Structure Initiative and is looking for scientists and other interested parties to respond to some questions about the program. Today's the last day, so if you're an interested party, check out this website to get involved.

Elsewhere, some working groups from ABRF are getting ready to launch the second phase of their DNA variant platform study (check out GT's article on the first phase here). They're looking for people to help benchmark technologies for tracking DNA variants, including sequencing, SNP genotyping, microsatellite analysis, and more. If you're interested in participating, fill out the survey here.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.